Anti TNF-α therapy can be a novel treatment option in patients with autoimmune hepatitis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 1, 2010, Pages 115-

  Efe, C ^a   Purnak, T ^b   Ozaslan, E ^b  

^a Internal Medicine Department   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; LETTER; LIVER FAILURE; PRIORITY JOURNAL; T LYMPHOCYTE;

HEPATITIS, AUTOIMMUNE; HUMANS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953183219     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04316.x     Document Type: Letter

References (5)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006 354 : 54 66.
2. Maggiore G, De Benedetti F, Massa M, et al. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 1995 20 : 23 7.
3. Yeoman AD, Longhi MS, Heneghan MA. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther 2010 31 : 771 787.
4. Tobon GJ, Cañas C, Jaller JJ, Restrepo JC, Anaya JM. Serious liver disease induced by infliximab. Clin Rheumatol 2007 26 : 578 581.
5. Weiler-Normann C, Wiegard C, Schramm C, et al. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade. Am J Gastroenterol 2009 104 : 2877 2878.